Summary
The non immunogenic mammary adenocarcinoma TS/A was transfected with the murine IL-2, IL-4, IFN-gamma genes. 3 clones releasing high levels of IL-2 or IL-4 or IFN-gamma were isolated. The ability of transfectants to form tumors after subcutaneous injection in syngeneic BALB/c mice was measured and compared to the parental TS/A (TS/A-pc) and to the cells transduced with neomicyn resistance gene alone (neo cells). All the cytokines released induced a LATI (Lymphokine-Activated Tumor Inhibition) which was more efficient after challenge with IL-2 and IL-4 transfected cells than after challenge with IFN-gamma transfected cells. The growth of a secondary contralateral challenge with TS/A-pc was significantly impaired after IL-2 and IL-4 induced tumor inhibition. The morphological data showed that the LATI rested on the recruitment of several cell reaction mechanisms, among which the ones considered as a specific seemed to predominate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Blakenstein, T., and Schreiber H. (1991) Cytokines and cancer: experimental systems. Curr. Opin. Immunol. 3:694–698.
Feigner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, J.M., and Danielsen, M. (1987) Lipofection: a highly efficient, lipid-mediated DNA- transfection procedure. Proc. Natl. Acad. Sci. USA 84:7413–7417.
Forni, G., Giovarelli, M., Forni, M., Modesti, A., and Santoni, A. (1987) Lymphokine-Activated Tumor Inhibition (LATI) in vivo. Lymphokines 14:335–360.
Forni, G., Giovarelli, M., Santoni, A., Modesti, A., and Forni, M. (1987) Interleukin-2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J. Immunol. 138:4033–4041.
Giovarelli, M., Santoni, A., Jemma, C., Musso, T., Giuffrida, A.M., Cavallo, C., Landolfo, S., and Forni, G. (1988) Obligatory role for IFN-gamma in induction of lymphokine-activated and T-lymphocyte killer activity, but not in boosting of natural cytotoxicity. J. Immunol. 141:2831–2836.
Karasuyama, H., Tohyama, N., and Tada, T. (1989) Autocrine growth and tumorigenicity of interleukin-2-dependent helper T cells transfected with IL-2 gene. J. Exp. Med. 169:13–25.
Lichtman, A.H., Kurt-Jones, E.A., and Abbas, A.K. (1987) B cell stimulatory factor 1 and not interleukin-2 is the autocrine growth factor for some helper T lymphocytes. Proc. Natl. Acad. Sci. USA 84:824–827.
Nanni, P., De Giovanni, C., Lollini, P.L., Nicoletti, G., and Prodi, G. (1983) TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma. Clin. Exp. Metastasis 1:373–380.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Basel AG
About this chapter
Cite this chapter
Brunetti, M. et al. (1993). Various Cytokines (IL-2, IL-4, IFN-gamma) Show Different Efficiency in Inducing Tumor Rejection. In: Cittadini, A., Baserga, R., Pinedo, H.M., Galeotti, T., Corda, D. (eds) Molecular Oncology and Clinical Applications. MCBU Molecular and Cell Biology Updates. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-5663-8_27
Download citation
DOI: https://doi.org/10.1007/978-3-0348-5663-8_27
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-5665-2
Online ISBN: 978-3-0348-5663-8
eBook Packages: Springer Book Archive